Zynerba Pharmaceuticals Inc. | Key People and Executives
Armando Anido
Chairman & Chief Executive Officer
Kenneth I. Moch
Independent Director
Daniel L. Kisner
Independent Director
Thomas L. Harrison
Independent Director
William J. Federici
Independent Director
Warren D. Cooper
Lead Independent Director
Armando Anido
Chairman & Chief Executive Officer
Terri B. Sebree
President
James E. Fickenscher
Chief Financial Officer & VP-Corporate Development
Liza Squires
Chief Medical Officer
Nancy Tich
Vice President-Clinical Operations
Donna L. Gutterman
Vice President-Medical
William C. Roberts
VP-Investor Relations & Corporate Communications
Suzanne M. Hanlon
Secretary, VP-Human Resources & General Counsel
Kenneth I. Moch
Independent Director
Daniel L. Kisner
Independent Director
Thomas L. Harrison
Independent Director
William J. Federici
Independent Director
Warren D. Cooper
Lead Independent Director
| Address |
80 West Lancaster Avenue
Devon Pennsylvania 19333
United States
|
|
Employees
|
- |
| Website |
http://zynerba.com |
| Updated |
07/08/2019 |
| Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. It engages in the development and commercialization of transdermal pharmaceutically-produced cannabinoid treatments for rare and near-rare neurological and psychiatric, or neuropsychiatric, disorders in patients with high unmet medical needs. The company was founded by Audra L. |
